Sandoz to acquire respiratory firm Oriel
Taskin Ahmed
Abstract
Sandoz, the generics division of Novartis is to acquire the private US pharmaceutical group Oriel Therapeutics.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.